Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI

MLA

Jianye Liang, et al. “Evaluating the Efficacy and Microenvironment Changes of HER2 + Gastric Cancer during HLX02 and Endostar Treatment Using Quantitative MRI.” BMC Cancer, vol. 22, no. 1, Oct. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12885-022-10136-y.

APA

Jianye Liang, Wei Dai, Zhipeng Li, Xiangjing Liang, Mingjia Xiao, Chuanmiao Xie, & Xinming Li. (2022). Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI. BMC Cancer, 22(1), 1–11. https://doi.org/10.1186/s12885-022-10136-y

Chicago

Jianye Liang, Wei Dai, Zhipeng Li, Xiangjing Liang, Mingjia Xiao, Chuanmiao Xie, and Xinming Li. 2022. “Evaluating the Efficacy and Microenvironment Changes of HER2 + Gastric Cancer during HLX02 and Endostar Treatment Using Quantitative MRI.” BMC Cancer 22 (1): 1–11. doi:10.1186/s12885-022-10136-y.